Editas med stock.
Below is a summary of how these 5 analysts rated Editas Medicine over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the ...
Editas Medicine Inc's trailing 12-month revenue is $24.6 million with a -792.7% profit margin. Year-over-year quarterly sales growth most recently was %.Editas Medicine (EDIT, $10.13) RSI Indicator left the overbought zone on November 21, 2023. Tickeron - Stocks • 5 days ago. Investors Buy High Volume of Editas Medicine Call Options (NASDAQ:EDIT) Zolmax • 6 days ago. Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information.12 Wall Street analysts have issued 1-year price objectives for Editas Medicine's stock. Their EDIT share price targets range from $7.00 to $30.00. On average, they expect the company's share price to reach $13.92 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price.May 5, 2023 · As of March 31, 2023, Editas Medicine had $401.8 million in cash, cash equivalents, and marketable securities, which is expected to fund their operating expenses and capital expenditures until 2025.
Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 5.2% so far this month. During the month of March, Editas Medicine Inc’s stock price has reached a high of $9.18 and a low of $8.45. Over the last year, Editas Medicine Inc has hit prices as high as $21.60 and as low as $7.71. Year to date, Editas ...Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently up 17.03% so far this month. During the month of May, Editas Medicine Inc’s stock price has reached a high of $10.71 and a low of $7.69. Over the last year, Editas Medicine Inc has hit prices as high as $19.97 and as low as $6.33. Year to date, Editas …
US$262,437,000 (2019) Number of employees. 208 [2] (2020) Website. www .editasmedicine .com. Editas Medicine, Inc., (formerly Gengine, Inc. ), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. [3] [4] Editas headquarters is located in Cambridge, Massachusetts and ...This week was a significant bounce back after Editas' shares stumbled following an announcement by the company on Jan. 9 that it was suspending some of its programs and cutting about 20% of its ...11.34%. Get the latest Editas Medicine Inc (EDIT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Take Editas Medicine (EDIT 2.28%) as an example. On June 9, it reported positive phase 1/2 data from one of its programs for sickle cell disease, then on June 14 it announced a stock offering ...Stifel has upgraded Editas Medicine Inc (NASDAQ: EDIT), saying the company's sickle cell disease candidate, EDIT-301's progress, has received minimal credit from investors.
Get the latest Editas Medicine, Inc. (EDIT) stock news and headlines to help you in your trading and investing decisions.
Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 13.39% so far this month. During the month of March, Editas Medicine Inc’s stock price has reached a high of $9.18 and a low of $7.48. Over the last year, Editas Medicine Inc has hit prices as high as $21.60 and as low as $7.71. Year to date, Editas ...
Nov 29, 2023 · Editas Medicine, Inc. - Hold. Zacks' proprietary data indicates that Editas Medicine, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the EDIT shares relative ... Stock Quote. Change Volume 52 Week High 52 Week Low Dec 2, 2023 5:42 PM EST. ... Editas Medicine, Inc. Phone: 617.401.0113 E-mail: [email protected] November 14, at a meeting with stock analysts, Editas CFO Erick Lucera said his company has at least two people working pretty much full time making calls and …View Editas Medicine, Inc EDIT investment & stock information. Get the latest Editas Medicine, Inc EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.
Stock Quote. Change Volume 52 Week High 52 Week Low Dec 2, 2023 5:42 PM EST. ... Editas Medicine, Inc. Phone: 617.401.0113 E-mail: [email protected] the latest Editas Medicine, Inc. (EDIT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The emergence of CRISPR. Editas Medicine's roots stretch back in a way at least to 1953, when James Watson and Francis Crick discovered the double-helix structure of deoxyribonucleic acid, or DNA ...EDIT - Editas Medicine Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Apr 17, 2023 · Shares of clinical-stage biotech Editas Medicine ( EDIT 3.66%) rose as much as 14% on Monday, lifted by a trend over the past couple of days favoring gene-editing stocks. Editas stock also ...
Both Editas and Gates’ office confirm that the Microsoft billionaire, who is the world’s richest man, is among the bng0 backers. Bill Gates: Beyond Microsoft, Money, Malaria. An eBook From ...
Nov 8, 2021 · Shares of Editas Medicine ( EDIT 11.39%) were jumping 9.4% as of 12:27 p.m. EST on Monday. The gain came after the company provided its third-quarter update earlier in the day. Editas reported ... Find out the direct holders, institutional holders and mutual fund holders for Editas Medicine, Inc. (EDIT).The Editas Medicine management team will host a conference call and webcast today at 8:00 a.m. ET to provide and discuss a corporate update and financial results for the first quarter of 2023. To ...Discover historical prices for EDIT stock on Yahoo Finance. View daily, weekly or monthly format back to when Editas Medicine, Inc. stock was issued.Complete Editas Medicine Inc. stock information by Barron's. View real-time EDIT stock price and news, along with industry-best analysis. Mar 10, 2023 · Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 13.39% so far this month. During the month of March, Editas Medicine Inc’s stock price has reached a high of $9.18 and a low of $7.48. Over the last year, Editas Medicine Inc has hit prices as high as $21.60 and as low as $7.71. Year to date, Editas ... See the latest Editas Medicine Inc stock price (EDIT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.December 4, 2014. Last month in Silicon Valley, biologists Jennifer Doudna and Emmanuelle Charpentier showed up in black gowns to receive the $3 million Breakthrough Prize, a glitzy award put on ...Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Innovative biochemist with experience leading projects and people. | Learn more about Chrysa Latrick's work experience, education, connections & more by visiting their profile on LinkedIn
Funding could be an issue. Editas Medicine ended the first quarter with $401.8 million in cash and equivalents, down from the $437.4 million it had at the end of 2022. In its quarterly update, the ...
11 ago 2021 ... The stock price of Editas Medicine, a biotechnology company focused on developing treatments using gene editing technology, has seen a rise ...
Editas Medicine is the exclusive licensee of Harvard and Broad Institute’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines.So, the natural question for Editas Medicine (NASDAQ: ... (PTMN), a business loan provider. Below, we look at the top 10 dividend stocks listed on either the New York Stock Exchange (NYSE) or ...The low in the last 52 weeks of Editas Medicine stock was 6.08. According to the current price, Editas Medicine is 174.67% away from the 52-week low. What was the 52-week high for Editas Medicine ... Editas Medicine Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 10.97. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 3.528%. Pessimistic target level: 10.80. Optimistic target level: 11.19.Name. Chg %. Market Cap. Molecular Templates Inc. 2.25%. $26.23M. EDIT | Complete Editas Medicine Inc. stock news by MarketWatch. View real-time stock prices and …Top Performers. Earnings Gainers. Earnings Stalwarts. Safe (er) Stocks. Top Dividend Stocks. Stocks Under $10. Defensive Picks. Compare stocks to their industry peers at U.S. News Best Stocks.Investment Thesis. Earlier this year, I wrote an article highlighting Editas Medicine's ( NASDAQ: EDIT) sluggish pace in which it is advancing its drug development programs. Since then, the ...Additionally, Editas Medicine announced the appointment of Emma Reeve, former Chief Financial Officer of Constellation Pharmaceuticals, as Chair of the Board, in place of outgoing Executive Chair ...Editas Medicine (EDIT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.A high-level overview of Editas Medicine, Inc. (EDIT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Editas (EDIT) delivered earnings and revenue surprises of 14.06% and 5.50%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. Editas Medicine, Inc. 2020 Q2 - Results - Earnings Call Presentation. SA Transcripts Thu, Aug. 06, 2020. 1 2. All earnings call transcripts on Editas Medicine, Inc. (EDIT) stock. Read or listen to ...Instagram:https://instagram. boost 5g networkcedarfxaarp dental plans reviewsbest brokers with low spreads Aug 2, 2023 · The Editas Medicine management team will host a conference call and webcast today at 8:00 a.m. ET to provide and discuss a corporate update and financial results for the second quarter of 2023. To access the call, please dial 1-877-407-0989 (domestic) or 1-201-389-0921 (international) and ask for the Editas Medicine earnings call. Jan 13, 2022 · Shares of Editas Medicine ( EDIT -2.58%) were tumbling 13% lower this week as of the market close on Thursday, based on data from S&P Global Market Intelligence. The company presented at the ... fhyvxbest monthly etf Jun 20, 2023 · On June 15, Editas Medicine ( EDIT 3.66%) saw its shares collapse by 15% after announcing it would be issuing new stock to raise approximately $125 million. The biotech will almost certainly use ... Click on the text tab and select a style of your choice. Change the size and color of the selected font to make it fit your design. You can also add some fun elements to make your 2048 x 1152 pixels YouTube channel art-pop. Select the ‘ Objects ’ bar and put in elements that fit the theme of your YouTube banner. how much are 1976 quarters worth Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, ... Editas Medicine Inc (NASDAQ:EDIT) Real-Time Quotes. 10.68. BATS BZX Real-Time Price. As of 3:23pm ETShares of Editas Medicine ( EDIT 3.07%), a clinical-stage biotech company, fell by 15.5% in November, according to data from S&P Global Intelligence. The stock closed October at $12.55 a share ...